The Fort Worth Press - Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

USD -
AED 3.672498
AFN 63.500226
ALL 81.989693
AMD 370.903715
ANG 1.789884
AOA 917.999784
ARS 1402.000098
AUD 1.396746
AWG 1.8025
AZN 1.699188
BAM 1.67146
BBD 2.014355
BDT 122.739548
BGN 1.668102
BHD 0.377403
BIF 2975
BMD 1
BND 1.275858
BOB 6.936925
BRL 4.965799
BSD 1.000128
BTN 95.070143
BWP 13.576443
BYN 2.828953
BYR 19600
BZD 2.011854
CAD 1.36153
CDF 2315.999805
CHF 0.783398
CLF 0.023178
CLP 912.220092
CNY 6.83025
CNH 6.83163
COP 3728.45
CRC 454.739685
CUC 1
CUP 26.5
CVE 94.649854
CZK 20.863102
DJF 177.719988
DKK 6.392905
DOP 59.596993
DZD 132.562995
EGP 53.660352
ERN 15
ETB 157.074988
EUR 0.855503
FJD 2.198802
FKP 0.736222
GBP 0.738305
GEL 2.684984
GGP 0.736222
GHS 11.195007
GIP 0.736222
GMD 73.498322
GNF 8777.503129
GTQ 7.643867
GYD 209.252937
HKD 7.83585
HNL 26.629906
HRK 6.445802
HTG 130.892468
HUF 311.15098
IDR 17419.2
ILS 2.947805
IMP 0.736222
INR 95.333649
IQD 1310
IRR 1315000.000107
ISK 122.679729
JEP 0.736222
JMD 157.565709
JOD 0.709005
JPY 157.436027
KES 129.150177
KGS 87.420501
KHR 4011.999694
KMF 420.50685
KPW 899.999998
KRW 1474.120278
KWD 0.308102
KYD 0.833593
KZT 463.980036
LAK 21962.504962
LBP 89401.229103
LKR 319.60688
LRD 183.625023
LSL 16.829718
LTL 2.95274
LVL 0.60489
LYD 6.335001
MAD 9.247017
MDL 17.22053
MGA 4155.000255
MKD 52.735603
MMK 2099.74975
MNT 3576.675528
MOP 8.070745
MRU 39.950163
MUR 46.949504
MVR 15.455028
MWK 1741.497487
MXN 17.487198
MYR 3.962502
MZN 63.910052
NAD 16.830396
NGN 1370.140154
NIO 36.719632
NOK 9.2596
NPR 152.110449
NZD 1.700895
OMR 0.384505
PAB 1.000329
PEN 3.506027
PGK 4.332505
PHP 61.531972
PKR 278.749815
PLN 3.63948
PYG 6218.192229
QAR 3.642952
RON 4.447703
RSD 100.428019
RUB 75.350017
RWF 1460.5
SAR 3.752195
SBD 8.025868
SCR 13.358429
SDG 600.49606
SEK 9.27985
SGD 1.27697
SHP 0.746601
SLE 24.649912
SLL 20969.496166
SOS 571.528078
SRD 37.456006
STD 20697.981008
STN 21.15
SVC 8.752948
SYP 110.524984
SZL 16.829942
THB 32.733991
TJS 9.363182
TMT 3.505
TND 2.885503
TOP 2.40776
TRY 45.219986
TTD 6.794204
TWD 31.595903
TZS 2597.49876
UAH 44.075497
UGX 3753.577989
UYU 40.286638
UZS 11997.999804
VES 488.94275
VND 26318.5
VUV 118.778782
WST 2.715188
XAF 560.591908
XAG 0.013563
XAU 0.000219
XCD 2.70255
XCG 1.8029
XDR 0.69563
XOF 558.500677
XPF 102.375019
YER 238.625008
ZAR 16.781905
ZMK 9001.198863
ZMW 18.731492
ZWL 321.999592
  • JRI

    -0.0500

    12.93

    -0.39%

  • BCC

    -3.8000

    74.33

    -5.11%

  • RIO

    -1.9500

    98.63

    -1.98%

  • NGG

    -0.9800

    87.5

    -1.12%

  • AZN

    -1.2800

    183.46

    -0.7%

  • BTI

    -0.3600

    58.35

    -0.62%

  • CMSD

    -0.0300

    23.25

    -0.13%

  • CMSC

    -0.0100

    22.87

    -0.04%

  • BCE

    -0.0300

    23.93

    -0.13%

  • GSK

    -0.7100

    50.9

    -1.39%

  • RBGPF

    1.6000

    64.7

    +2.47%

  • RYCEF

    -0.0200

    16.33

    -0.12%

  • VOD

    -0.1000

    16.05

    -0.62%

  • RELX

    0.0100

    36.36

    +0.03%

  • BP

    0.5300

    46.94

    +1.13%

Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

LAS VEGAS, NV / ACCESS Newswire / March 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Apollo Hospitals (Apollo) and Ainnova have officially established a strategic collaboration that marks a significant step forward in the integration of artificial intelligence into disease detection and prediction.

Text size:

As part of this alliance, Ainnova has secured an exclusive license for several advanced AI algorithms, which have been rigorously validated with over 2.3 million data points and now form an integral part of Ainnova's Vision AI platform. These cutting-edge solutions enable the early and precise detection of conditions, such as cardiovascular disease (CVD), chronic kidney disease (CKD), liver fibrosis, type 2 Diabetes, and lung abnormalities in CT scans and X-rays, including lung cancer.

Last month, Avant and Ainnova signed a global development and licensing deal for Ai-Nova Acquisition Corp. (AAC), the joint venture formed by both companies. Given AAC's territory now includes a global license to develop and market Ainnova's technology portfolio, this partnership with Apollo strengthens the joint venture's efforts to advance AI in Healthcare using Ainnova's Vision AI platform and its proprietary versatile retinal camera technology.

This week, most of these AI-driven diagnostics will be available exclusively on the Vision AI platform across the Americas, where the first commercial pilot programs are set to launch in the coming weeks.

Notably, Brazil is already included in the expansion roadmap, as the partnership has successfully met the regulatory requirements set by ANVISA (Brazilian Health Regulatory Agency). This milestone paves the way for commercialization in a country with over 200-million people.

The integration of these AI-powered solutions aligns with efforts to enhance chronic disease management by adding substantial value to patient care. By providing a comprehensive preventive health assessment, these tools aim to facilitate early referrals from primary care providers or community health services, such as pharmacies, to specialized medical professionals.

Apollo Hospitals is one of the largest and most renowned private healthcare networks in Asia, playing a leading role in transforming healthcare in India and across Southeast Asia. With a robust presence that includes hospitals, clinics, pharmacies, and diagnostic centers in the region and beyond, Apollo remains at the forefront of medical innovation.

With this alliance, Apollo reaffirms its commitment to advancing global healthcare by leveraging AI-powered solutions. Partnering with Ainnova in the Americas underscores its dedication to driving innovation, improving patient outcomes, and expanding access to state-of-the-art medical technologies. Together, the two organizations will continue to develop and deploy AI-driven healthcare solutions with additional innovations set to be introduced in the near future.

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce VisionAI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Apollo Hospitals

Apollo revolutionized healthcare when Dr. Prathap Reddy opened the first hospital in Chennai in 1983. Today, Apollo is India's largest integrated healthcare platform with over 10,000 beds across 73 hospitals, over 6000 pharmacies and over 200 clinics and diagnostic centers, as well as 150 telemedicine centers. It is the world's leading cardiac center with over 200,000 surgeries and the world's largest private cancer care provider. Apollo continues to invest in research to bring the most cutting-edge technologies, equipment, and treatment protocols to ensure patients have the best available care in the world. Apollo's 100,000 family members are dedicated to bringing you the best care and leaving the world better than we found it.

About Avant Technologies, Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI

https://www.linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies, Inc.
[email protected]

SOURCE: Avant Technologies



View the original press release on ACCESS Newswire

T.Mason--TFWP